Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Oral heart failure drug receives FDA’s fast track designation
A clinical trial focused on patients with HFpEF is expected to be completed by July 2026.
Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in
Boston Scientific stopped selling its Acurate TAVR systems after they underperformed in a few key trials and failed to gain FDA approval. Was it the right call?
FDA clears new ‘smart shirt’ for real-time cardiopulmonary monitoring
According to Hexoskin, the newly cleared technology offers significant value for hospitals and health systems as well as researchers conducting clinical trials.
Drones deliver AEDs for the first time in the United States
“This study represents a major step forward in how we respond to cardiac arrest in the United States,” explained Monique Starks, MD, principal investigator. “By integrating drone technology into emergency care, we’re working to close the critical gap between cardiac arrest and treatment."
Canon introduces new combined CT-angiography interventional system
Jaimin Chung, director of Canon Medical’s interventional X-ray and vascular business unit, explains the technology behind a new combined CT angiography interventional system aimed at neurology, trauma, stroke and pediatrics that recently received 510(k) FDA clearance.

Atraverse Medical raises $29M to support FDA-approved heart tech

The San Diego-based startup gained FDA approval for its Hotwire RF guidewire in 2024. The technology has already been used to perform hundreds of heart procedures.

Statue of Liberty New York City healthcare

Late-breaking clinical trials announced for New York Valves 2025

The three-day event is now in its second year. Each day will feature late-breaking clinical trials focused on a different heart valve.

Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

FDA recalls Zyno infusion pumps, citing risk of death

Some infusion systems manufactured by Zyno Medical were released with unapproved software that could cause safety features to malfunction. Use of any device subject to the recall is to cease immediately.

Why more doctors should pursue business and leadership training

“Just as medicine has its own language, so does business," two surgeons explained in a new editorial.

Inquis Medical Aventus Thrombectomy System

FDA clears blood clot removal system for treating pulmonary embolism

The Aventus Thrombectomy System was already cleared to treat blood clots in the peripheral arteries. This latest approval comes after positive results from an IDE study were published in JSCAI.

Next-day discharge after TAVR is still safe when alternative access is required

Even TAVR patients not treated using transfemoral access can typically go home the very next day.

Signs of Alzheimer's evident on imaging up to 15 years prior to symptom onset in Down syndrome population

By identifying these structural changes prior to the onset of symptomatic neurodegeneration, providers may be able to initiate preventive therapies sooner.

Clinical

Oral heart failure drug receives FDA’s fast track designation

Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in

FDA clears new ‘smart shirt’ for real-time cardiopulmonary monitoring

Drones deliver AEDs for the first time in the United States

Canon introduces new combined CT-angiography interventional system